Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H14O5 |
| Molecular Weight | 238.2366 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(\C=C\C(O)=O)=CC=C1OCCO
InChI
InChIKey=YNUMZJCKFQVSRH-HWKANZROSA-N
InChI=1S/C12H14O5/c1-16-11-8-9(3-5-12(14)15)2-4-10(11)17-7-6-13/h2-5,8,13H,6-7H2,1H3,(H,14,15)/b5-3+
| Molecular Formula | C12H14O5 |
| Molecular Weight | 238.2366 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Cinnamic acid is an odorless white crystalline acid that has only been recently studied for its potential in cancer prevention. Cinnamic acid and its derivatives are the major group of phenolic acids with ubiquitous distribution in fruits and vegetables. Preclinical data support the beneficial effects of Cinnamic acid, including antioxidant, anti-inflammatory, and anti-cancer activities. A more recent botanical review noted that cinnamic acid may help pre-diabetic and diabetic patients. When infected mice were fed food loaded with cinnamic acid, researchers saw that their insulin levels were better managed. Another study which used mice models saw that cinnamic acid improved glucose tolerance by promoting insulin secretion.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:31:53 GMT 2025
by
admin
on
Mon Mar 31 18:31:53 GMT 2025
|
| Record UNII |
3E3106052Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66913
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
252-684-7
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
C81551
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
m118
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
21113
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | RxNorm | ||
|
100000081058
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
649
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
C007066
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
SUB06283MIG
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
3035
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104040
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
6436159
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
DTXSID001043324
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
35703-32-3
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY | |||
|
3E3106052Y
Created by
admin on Mon Mar 31 18:31:53 GMT 2025 , Edited by admin on Mon Mar 31 18:31:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |